Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling-Reference-Cited by-同舟云学术

Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling

Published:2020-10-30 Issue:2 Volume:39 Page:416-425
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Lu Minan,Xie Kegong,Lu Xianzhe,Lu Lu,Shi Yu,Tang Yujin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-020-01027-9.pdf

Reference34 articles.

1. Misaghi A, Goldin A, Awad M, Kulidjian AA (2018) Osteosarcoma: a comprehensive review. SICOT J 4:12. https://doi.org/10.1051/sicotj/2017028

2. Anderson ME (2016) Update on Survival in Osteosarcoma. Orthop Clin North Am 47:283–292. https://doi.org/10.1016/j.ocl.2015.08.022

3. Marina NM, Smeland S, Bielack SS et al (2016) Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol 17:1396–1408. https://doi.org/10.1016/S1470-2045(16)30214-5

4. O'Kane GM, Cadoo KA, Walsh EM et al (2015) Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review. Clin Sarcoma Res 5:17. https://doi.org/10.1186/s13569-015-0032-0

5. Zheng Y, Wang G, Chen R, Hua Y, Cai Z (2018) Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications. Stem Cell Res Ther 9:22. https://doi.org/10.1186/s13287-018-0780-x

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer;Molecular Biotechnology;2024-04-02

2. Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia;Neuro-Oncology;2024-03-30

3. Shuangshen Granules Suppress Myeloid-derived Suppressor Cell-mediated Lung Premetastatic Niche Development by Targeting Sphingosine-1-Phosphate Receptor-1/Signal Transducer, Activator of Transcription 3 Signaling;World Journal of Traditional Chinese Medicine;2024-03-19

4. Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells;Frontiers in Pharmacology;2024-02-14

5. Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets;Medicine;2024-01-19